Levine Cancer Institute At Atrium Health

SAN ANTONIO — The addition of palbociclib to standard care extended median PFS for patients with hormone receptor-positive, HER2-positive metastatic breast cancer, according to study results presented at San Antonio Breast Cancer Symposium.

SAN DIEGO — Successfully addressing financial toxicity for people with blood cancer will require substantial efforts from a variety of stakeholders, according to a speaker at ASH Annual Meeting and Exposition.

Advancing equitable access to palliative care will require interdisciplinary collaboration and effective communication, according to several leaders in the field.

Dental extractions after radiation therapy to the head and neck should not be routinely performed due to considerable risk, according to results of a prospective cohort study.

According to Ashley L. Sumrall, MD, there’s not a great deal of difference between a practicing oncologist and a physician advocate.

A woman in her late 50s is currently receiving treatment for her second bout of breast cancer. She is thought to be in remission, but Neelam Desai, MD, worries about more than just the disease.

An estimated 10% to 40% of patients with solid tumors develop brain metastases.

Breast cancer accounts for nearly one-third of new cancer diagnoses among women in the United States.

The FDA approved momelotinib for treatment of patients with myelofibrosis and anemia regardless of prior myelofibrosis therapy.

After decades of developmental challenges, antibody-drug conjugates have emerged as potentially less toxic and more effective treatment options for a variety of malignancies.